A strategic thinker at heart, Meaghan has the keen ability to lead integrated, cross-disciplinary teams across HCP, patient, and payer initiatives, encompassing digital, offline, branded, and unbranded. She has focused on biopharma throughout her tenure, including areas such as oncology, immunology, HIV, and HCV. Meaghan received her master’s in sociolinguistics from Georgetown University in 2002. She leverages her training as a sociolinguist to drive selection of the right language to inspire concise and clear communications, and ultimately foster a successful brand lexicon. Meaghan’s contribution to the field of HCP-patient dialogue includes 39 peer-reviewed publications.